Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Evolv Technologies Holdings, Inc.EVLV · Entity 5017 | Director | August 17, 2026 | August 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Evolv Technologies Holdings, Inc.
Report date August 17, 2026 · Filed August 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,083,961 |
Ending reported balance
After 2026-08-17 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-08-17 · Exercise / conversion · Acquired 80,752 · Balance 2,164,713 Row 2 · 2026-08-17 · Sale · Disposed 80,752 · Balance 2,083,961 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025. F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.24 · Expires 2027-09-13 | Direct | 816,262 |
Reported balance
After 2026-08-17 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-08-17 · Exercise / conversion · Disposed 80,752 · Balance 816,262 F3: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter. |
| Class A Common StockSEC Table I · non-derivative | IndirectHeld by Family Horizon Trust | 151,135 |
Reported balance
Holding disclosure · report date 2026-08-17 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 151,135 |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on June 12, 2025.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: The option vested and became exercisable as to 25% on January 31, 2018 and vested in 36 equal monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 57,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · nonDerivative · entry 3 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,140,224 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 66,767 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,082,832 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2025 Filed Mar 4, 2025 21:11 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 47,765 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-009839 · wk-form4_1741122663.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,016,065 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 22:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 38,356 | $3.63 | $139,232.28 |
DisclosureSEC source: 0001628280-24-009037 · wk-form4_1709677364.xml · nonDerivative · entry 3 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,968,300 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.61 to $3.68. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:21 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 225,631 | $0.00 Strike: $3.63 | $0.00 |
DisclosureSEC source: 0001628280-24-009461 · wk-form4_1709763683.xml · derivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,631 Underlying: Class A Common Stock · 225,631 shares Expires 2034-03-03 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2024 and in 15 equal quarterly installments thereafter. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:21 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 172,176 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009461 · wk-form4_1709763683.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,176 Underlying: Class A Common Stock · 172,176 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2025. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 66,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009037 · wk-form4_1709677364.xml · derivative · entry 7 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,554 Underlying: Class A Common Stock · 66,766 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F5 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 47,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009037 · wk-form4_1709677364.xml · derivative · entry 6 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,765 Underlying: Class A Common Stock · 47,751 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F4 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 66,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009037 · wk-form4_1709677364.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,006,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:23 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 47,751 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009037 · wk-form4_1709677364.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,939,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 21:26 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,334 | $5.22 | $435,003.48 |
DisclosureSEC source: 0001628280-24-005916 · wk-form4_1708550756.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,892,139 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.38. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 08, 2024 Filed Feb 10, 2024 01:38 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 54,873 | $5.04 | $276,559.92 |
DisclosureSEC source: 0001628280-24-004139 · wk-form4_1707529116.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,975,473 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.07. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 14:02 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 41,667 | $4.22 | $175,834.74 |
DisclosureSEC source: 0001628280-24-001608 · wk-form4_1705586545.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,030,346 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.16 to $4.32. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 03, 2024 Filed Jan 4, 2024 00:38 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 915 | $4.53 | $4,144.95 |
DisclosureSEC source: 0001628280-24-000350 · wk-form4_1704328684.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,072,013 F2 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the January 1, 2024 vesting of the RSUs described in footnote 1. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:38 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000350 · wk-form4_1704328684.xml · derivative · entry 5 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2024 Filed Jan 4, 2024 00:38 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-000350 · wk-form4_1704328684.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,072,928 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs vested on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 21:56 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 2,600 | $5.00 | $13,000.00 |
DisclosureSEC source: 0001628280-23-042936 · wk-form4_1703886957.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,070,428 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| December 27, 2023 Filed Dec 28, 2023 21:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 609 | $5.00 | $3,045.00 |
DisclosureSEC source: 0001628280-23-042811 · wk-form4_1703800098.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,073,028 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 21:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 79,371 | $5.01 | $397,648.71 |
DisclosureSEC source: 0001628280-23-042811 · wk-form4_1703800098.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,073,637 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.04 The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 19, 2023 Filed Dec 20, 2023 22:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 29,215 | $5.01 | $146,367.15 |
DisclosureSEC source: 0001628280-23-042299 · wk-form4_1703110436.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,153,008 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.04. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 18, 2023 Filed Dec 20, 2023 22:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 41,667 | $4.82 | $200,834.94 |
DisclosureSEC source: 0001628280-23-042299 · wk-form4_1703110436.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,182,223 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.74 to $4.88. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2023 Filed Nov 20, 2023 14:20 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 41,567 | $4.01 | $166,683.67 |
DisclosureSEC source: 0001628280-23-039569 · wk-form4_1700490046.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,223,890 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 16, 2023 Filed Nov 20, 2023 14:20 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 100 | $4.00 | $400.00 |
DisclosureSEC source: 0001628280-23-039569 · wk-form4_1700490046.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,265,457 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| October 24, 2023 Filed Oct 25, 2023 21:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 34,201 | $4.03 | $137,830.03 |
DisclosureSEC source: 0001628280-23-035141 · wk-form4_1698268621.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,265,557 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.08. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 23, 2023 Filed Oct 25, 2023 21:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 7,466 | $4.00 | $29,864.00 |
DisclosureSEC source: 0001628280-23-035141 · wk-form4_1698268621.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,299,758 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.01. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 18, 2023 Filed Sep 19, 2023 20:48 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,334 | $5.63 | $469,170.42 |
DisclosureSEC source: 0001628280-23-032539 · wk-form4_1695156510.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,307,224 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.55 to $5.71. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 16, 2023 Filed Aug 18, 2023 01:58 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,334 | $7.26 | $605,004.84 |
DisclosureSEC source: 0001628280-23-029920 · wk-form4_1692323880.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,390,558 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.73. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 17, 2023 Filed Jul 18, 2023 20:35 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,334 | $6.74 | $561,671.16 |
DisclosureSEC source: 0001628280-23-025073 · wk-form4_1689712492.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,473,892 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.92 to $6.95. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 20, 2023 23:14 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,332 | $6.14 | $511,658.48 |
DisclosureSEC source: 0001628280-23-022774 · wk-form4_1687302881.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,557,226 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.07 to $6.32. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 16, 2023 Filed May 17, 2023 20:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,332 | $5.31 | $442,492.92 |
DisclosureSEC source: 0001628280-23-018667 · wf-form4_168435396026108.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,640,558 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.13 to $5.54. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 11, 2023 Filed May 15, 2023 20:56 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 83,332 | $5.01 | $417,493.32 |
DisclosureSEC source: 0001628280-23-018243 · wf-form4_168418416376928.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,723,890 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 to $5.05. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 09, 2023 Filed May 10, 2023 20:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 82,532 | $4.03 | $332,603.96 |
DisclosureSEC source: 0001628280-23-017265 · wf-form4_168375059255292.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,807,222 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.00 to $4.09. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 08, 2023 Filed May 10, 2023 20:30 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 800 | $4.00 | $3,200.00 |
DisclosureSEC source: 0001628280-23-017265 · wf-form4_168375059255292.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,889,754 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into on December 16, 2022. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:28 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 265,957 | $0.00 Strike: $3.12 | $0.00 |
DisclosureSEC source: 0001628280-23-006714 · wf-form4_167822451853534.xml · derivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 265,957 Underlying: Class A Common Stock · 265,957 shares Expires 2033-03-02 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to one sixteenth of the underlying shares on June 1, 2023 and in 15 equal quarterly installments thereafter. Read SEC document |
| March 03, 2023 Filed Mar 7, 2023 21:28 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 200,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006714 · wf-form4_167822451853534.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,320 Underlying: Class A Common Stock · 200,320 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2024. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 02, 2023 Filed Mar 3, 2023 22:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 16,070 | $2.92 | $46,924.40 |
DisclosureSEC source: 0001628280-23-006342 · wf-form4_167788182528211.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,890,554 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of RSUs. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 47,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006342 · wf-form4_167788182528211.xml · derivative · entry 5 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,516 Underlying: Class A Common Stock · 47,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F3 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F2 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:17 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 47,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-006342 · wf-form4_167788182528211.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 05, 2023 Filed Jan 9, 2023 23:36 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 963 | $2.37 | $2,282.31 |
DisclosureSEC source: 0001628280-23-000782 · wf-form4_167330736231912.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,858,874 F1 · shares: The sale reported in the Form 4 was effected solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.37 to $2.40. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:24 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000359 · wf-form4_167288188080009.xml · derivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Class A Common Stock · 2,500 shares Expires not disclosed F1 · derivative.exercise_price: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.exercise_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. F1 · derivative.expiration_date: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| January 01, 2023 Filed Jan 5, 2023 01:24 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantClass A Common Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-23-000359 · wf-form4_167288188080009.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,859,837 F1 · shares: On March 31, 2022, the reporting person was granted 5,000 performance-based restricted stock units ("RSUs"). 50% of the performance-based RSUs vested on January 1, 2023 based on achieving an annual bookings goal for the fiscal year ended December 31, 2022. The remaining RSUs will vest on January 1, 2024, subject to the reporting person's continued employment through such vesting date. Each RSU represents a contingent right to receive one share of Class A Common Stock and has no expiration date. Read SEC document |
| September 22, 2022 Filed Sep 23, 2022 20:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | SaleClass A Common Stock | 151 | $2.10 | $317.10 |
DisclosureSEC source: 0001104659-22-102692 · tm2226581-3_4seq1.xml · nonDerivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857,337 F2 · kind: The sale reported in the Form 4 was effected pursuant to a standing Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported RSUs. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.10 to $2.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-102692 · tm2226581-3_4seq1.xml · derivative · entry 3 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.exercise_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| September 21, 2022 Filed Sep 23, 2022 20:27 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | Exercise / conversionClass A Common Stock | 500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-22-102692 · tm2226581-3_4seq1.xml · nonDerivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,857,488 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On September 27, 2021, the reporting person was granted 500 restricted stock units ("RSU"), vesting on September 21, 2022. Each RSU represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 215,517 | $0.00 Strike: $2.32 | $0.00 |
DisclosureSEC source: 0001104659-22-030226 · tm228072-5_4seq1.xml · derivative · entry 2 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Head of Adv. Tech. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,517 Underlying: Class A Common Stock · 215,517 shares Expires 2032-02-29 F3 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| March 01, 2022 Filed Mar 4, 2022 01:15 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 143,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-030226 · tm228072-5_4seq1.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Head of Adv. Tech. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,266 Underlying: Class A Common Stock · 143,266 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F2 · derivative.exercise_date: The RSUs vest in three equal annual installments commencing on March 1, 2023. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| March 01, 2022 Filed Sep 16, 2022 00:44 UTC Amendment | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantStock Option (Right to Buy) · Derivative | 215,517 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0001628280-22-025045 · wf-form4a_166328907799625.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Chief Innovation Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,517 Underlying: Class A Common Stock · 215,517 shares Expires 2032-02-29 F1 · derivative.exercise_date: The stock option vests and becomes exercisable as to 25% of the underlying shares on March 1, 2023 and in 12 equal quarterly installments thereafter. Read SEC document |
| September 27, 2021 Filed Sep 28, 2021 20:18 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantRestricted Stock Units · Derivative | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-21-120239 · tm2128583-3_4seq1.xml · derivative · entry 1 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Head of Adv. Tech. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500 Underlying: Class A Common Stock · 500 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. F1 · derivative.expiration_date: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A common stock. The RSUs have no expiration date. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantPerformance Rights · Derivative | 273,313 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094060 · tm2122604-11_4seq1.xml · derivative · entry 9 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Head of Adv. Tech. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by E Ventures Trust Disclosed balance after: 273,313 Underlying: Class A Common Stock · 273,313 shares Expires not disclosed F5 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F5 · price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. Read SEC document |
| July 16, 2021 Filed Jul 20, 2021 22:06 UTC | Evolv Technologies Holdings, Inc. EVLV · Entity 5017 | GrantPerformance Rights · Derivative | 18,278 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-21-094060 · tm2122604-11_4seq1.xml · derivative · entry 8 Ellenbogen Michael · CIK 0001869206 · Director · Founder & Head of Adv. Tech. 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Family Horizon Trust Disclosed balance after: 18,278 Underlying: Class A Common Stock · 18,278 shares Expires not disclosed F5 · derivative.exercise_price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F1 · shares: The Reporting Person acquired these securities on July 16, 2021 as consideration and in exchange for the Reporting Person's holdings in Evolv Technologies, Inc. ("Old Evolv") pursuant to an Agreement and Plan of Merger dated March 5, 2021, by and among Old Evolv, NewHold Investments Corp. (the predecessor to Issuer) and NHIC Sub Inc., as amended by that certain First Amendment to Agreement and Plan of Merger dated June 5, 2021 (as so amended, the "Merger Agreement"). F5 · price: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.exercise_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. F5 · derivative.expiration_date: Each performance right represents a contingent right to receive one share of the Issuer's Class A common stock. Pursuant to an "Earn Out" provision in the Merger Agreement, the performance rights vest upon the Issuer's Class A Common stock achieving a specified price per share as follows: (i) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $12.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; (ii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $15.00 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026; and (iii) 1/3 of the shares shall be issued if the closing sale price of Class A common stock equals or exceeds $17.50 per share for any period of 20 trading days out of 30 consecutive trading days prior to March 5, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.